Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma

Yazar: Di Lauro, Luigi, Giacinti, Laura, Arena, Maria Grazia, Sergi, Domenico, Fattoruso, Silvia Ileana, Giannarelli, Diana, Lopez, Massimo
Baskı/Yayın Bilgisi 2009

FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort

Yazar: Maugeri-Saccà, Marcello, Pizzuti, Laura, Sergi, Domenico, Barba, Maddalena, Belli, Franca, Fattoruso, Silvia Ileana, Giannarelli, Diana, Amodio, Antonella, Boggia, Sara, Vici, Patrizia, Di Lauro, Luigi
Baskı/Yayın Bilgisi 2013

Quality of Life in Patients With Severe Skin Reactions in Course of First-Generation Epidermal Growth Factor Receptor Inhibitors Monoclonal Antibodies (Our Experience With Cetuxima...

Yazar: De Luca, Rossella, Lo Coco, Gianluca, Addeo, Raffaele, Fattoruso, Silvia Ileana Sara, Auriemma, Annunziata, Paci, Roberta, Mistretta, Ornella, Epifanio, Maria Stella, Salvato, Angela, D’Agostino, Alberto, Cicero, Giuseppe
Yayımlandı World J Oncol (2021)